Avertix Medical
PrivateLast Round
Series C
Aug 10, 2024
Est. Valuation
$10.87M
Total Funding Raised
$14.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avertix Medical operates in Healthcare & Life Sciences and is based in Eatontown, New Jersey. Its latest recorded funding round was a Series C round in August 2024.
Avertix Medical is a medical technology company that develops and commercializes implantable cardiac monitoring devices for the detection of acute coronary syndrome events.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avertix Medical Comparables
Compare Avertix Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medtronic | 70% | |
| Cortex, Inc. | 69% | |
| BIOTRONIK | 67% |
For institutional investors. Book with your work email.
Avertix Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 10, 2024 | ||||
| Early Funding | Nov 13, 2023 | ||||
| M&A | Oct 5, 2023 | ||||
| Series B | Feb 10, 2023 | ||||
| VC Round | Mar 13, 2020 | ||||
VC Round | Dec 17, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avertix Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hydrix Ventures | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 100% MoM, reaching 3.3K.
- Apr 20, 2026
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
Avertix Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avertix Medical's valuation, stock price, and market status.
Is Avertix Medical a public or private company?
Avertix Medical is a private company.
What is the current stock price of Avertix Medical?
Avertix Medical is a private company, so its shares have no public market price. Caplight tracks Avertix Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avertix Medical worth (valuation)?
Avertix Medical's valuation is estimated at $10.9M based on funding round data.
Can I buy Avertix Medical stock?
Avertix Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avertix Medical's last funding round?
Avertix Medical's most recent funding round was Series C on August 10, 2024.
Who are the main investors in Avertix Medical?
Key investors in Avertix Medical include Hydrix Ventures.
Will Avertix Medical IPO soon?
No public IPO plans have been announced for Avertix Medical.
How can I track Avertix Medical secondary market activity?
Caplight tracks bids, offers, and trades in Avertix Medical's shares on secondary markets.